Insider trades

Brendan Hannah, COO of Quince Therapeutics QNCX, has filed 7 purchases and 0 sales on the open market. The latest trade was on 01/23.

Brendan Hannah

Cbo, COO & Cco
First filing
23/02/02
Trades
20 trades
Buys / sales
7 / 0
12-month net buying
No record
Last trade
01/23

Trading activity

Transactions

Trade type
QNCX
Open-market buy24/08/19–24/08/2124/08/2138,924 sh6 trades$0.62avg.$24,166.05+15.1%
Open-market buy23/08/0823/08/0971,762 sh$1.22$87,549.64+55.3%